Keywords
How to Cite
Abstract
Background: Vitamin D insufficiency/deficiency prevalent in all age groups across the world is common in obesity and may play an important role in the risk factors of metabolic syndrome (MS). Objectives: This cross-sectional study is to evaluate the relationship between levels of adiponectin and circulating 25(OH)D, and its effect on metabolic biomarker among overweight/obese female students. Methods: Three hundred female students; with mean age 20.9 ± 3.2 years were attending the Aljouf University, Sakaka, Saudi Arabia. They were randomly selected from university during the studying year 2015 – 2016. Anthropometric and biochemical indices were determined. Results: The study showed 19% of the female’s student were either overweight or obese (15% and 4%, respectively). The frequency of MS diagnosis among the students was 17%, with 13% and 4% had either three or four risk factors, respectively. Overweight/obese subjects had significantly worse anthropometric and biochemical characteristics, including waist/hip ratio, blood pressure (BP), fasting blood glucose (BG), insulin, insulin resistance (HOMA-IR), triglyceride levels (TG), low-density lipoprotein cholesterol levels (LDL-C), leptin, adiponectin, leptin/adiponectin ratio and high-density lipoprotein cholesterol levels (HDL-C) compared to normal weight. Of the subjects diagnosed with MS, 59% had mild and 8.6% had severe 25(OH)D deficiency. There was negative association between 25(OH)D and both FBG and HOMA-IR among young women obese/overweight. Conclusion: In our study, it suggested that low level of adiponectin was strongly correlated with low 25(OH)D levels. Also, the prevalence of MS tends to increase with high occurrence rate of low circulating 25(OH)D levels that is, known cause poor glycemic control and prediction of cardiovascular outcomes.
References
Bassil D, Rahme M, Hoteit M, Fuleihan GE-H. Hypovitaminosis D in the Middle East and North Africa: Prevalence, risk factors and impact on outcomes. Dermato-endocrin. 2013; 5(2):274-298.
Cheng S, Massaro JM, Fox CS, Larson MG, Keyes MJ, McCabe EL, et al. Adiposity, cardiometabolic risk, and vitamin D status: the Framingham Heart Study. Diabetes 2010; 59:242–248.
Pramyothin P, Biancuzzo RM, Lu Z, Hess DT, Apovian CM, Holick MF. Vitamin D in adipose tissue and serum 25-Hydroxyvitamin D after roux-en-Y gastric bypass. Obesity 2011; 19:2228–2234. Doi: 10.1038/oby.2011.170.
Pittas AG, Chung M, Trikalinos T, Mitri J, Brendel M, Patel K, et al, Systematic review: vitamin D and cardiometabolic outcomes. Ann Int Med. 2010; 152(5):307-314.
Fung GJ, Steffen LM, Zhou X, Harnack L, Tang W, Lutsey PL, et al, Vitamin D intake is inversely related to risk of developing metabolic syndrome in African American and white men and women over 20 y: The Coronary Artery Risk Development in Young Adults study. Amer J Clin Nutr. 2012; 96(1):24-29.
Kayaniyil S, Vieth R, Retnakaran R, Knigh, JA, Qi Y, Gerstein HC, et al. Association of Vitamin D With Insulin Resistance and β -Cell Dysfunction in Subjects at Risk for Type 2 Diabetes. Diabetes Care. 2010; 33:1379- 81.
Wolfson N, Goldberg Y, Shargorodsky M. Adiponectin and vascular properties in obese patients: Is it a novel biomarker of early atherosclerosis? Int J Obesity. 2009; 3: 553–558.
Jéquier E. Leptin signaling, adiposity, and energy balance. Lipids and Insulin Resistance: The Role of Fatty Acid Metabolism and Fuel Partitioning,” Ann New York Academy Sci. 2002; 967: 379–388.
Salehpour A, Shidfar F, Hosseinpanah F, Vafa M, Razaghi M, Hoshiarrad A, et al, Vitamin D3 and the risk of CVD in overweight and obese women: a randomised controlled trial. Br J Nutr. 2012; 108(10):1866- 1873
Trumbo P, Schlicker S, Yates AA, Poos M. Dietary reference intakes for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein and amino acids. J Amer Diet Assoc. 2002; 102(11):1621- 1630.
Hambidge KM. Micronutrient bioavailability: Dietary Reference Intakes and a future perspective. Amerj Clin Nutr.2010; 91(5):1430S- 1432S.
Woo JG. Using body mass index z-score among severely obese adolescents: a cautionary note. Pediat Obes 2009; 4(4):405-410.
Pi-Sunyer, X. Clinical guidelines on the identification, evaluation and treatment of overweight and obesity in adults-the evidence report. Obes Res. 1998; 6:51S-210S.
Nagy E, Vicente-Rodriguez G, Manios Y, Béghin L, Iliescu C, Censi L, et al, Harmonization process and reliability assessment of anthropometric measurements in a multicenter study in adolescents. Intl J Obes. 2008; 32(S5): S58.
National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediat. 2004; 4 (2 Suppl), 555- 576.
Zimmet P1, Alberti KG, Kaufman F, Tajima N, SilinkM, Arslanian S. et al.. The metabolic syndrome in children and adolescents – an idfconsensus report. Pediat Diab.2007; 8: 299–306.
Matthews D, Hosker J, Rudenski A, Naylor B, Treacher D, Turner R. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia.1985; 28(7):412-419.
Holick MF, Siris ES, Binkley N, Beard MK, Khan A, Katzer JT, et al, Prevalence of vitamin D inadequacy among postmenopausal North American women receiving osteoporosis therapy. J Clinl Endocrin & Metab. 2005; 90(6):3215-3224.
Ashraf AP, Alvarez JA, Gower BA, Saenz KH, Mccormick KL. Associations of Serum 25- Hydroxyvitamin D and Components of the Metabolic Syndrome in Obese Adolescent Females. Obesity 2011; 19(11):2214-2221
Jackson JL, Judd SE, Panwar B, Howard VJ, Wadley VG, Jenny NS, et al. Associations of 25-hydroxyvitamin D with markers of inflammation, insulin resistance and obesity in black and white community-dwelling adults. J Clin Translat Endocrino. 2016; 5: 21–25. http://doi.org/10.1016/j.jcte.2016.06.002
Aleffi S, Petrai I, Bertolani C, Parola M, Colombatto S, Novo E et al. Upregulation of proinflammatory and proangiogenic cytokines by leptin in human hepatic stellate cells. Hepatology. 2005; 42:1339–48. https://doi.org/10.1002/hep.20965 .
Ouchi N, Walsh K. Adiponectin as an anti-inflammatory factor. Clin Chim Acta. 2007; 380:24–30. https://doi.org/10.1016/j.cca.2007.01.026 .
Al-Daghri NM, Al-Attas OS, Alokail MS, Alkharfy KM, Al-Othman A, Draz HM, et al. Hypovitaminosis D associations with adverse metabolic parameters are accentuated in patients with Type 2 diabetes mellitus: a body mass index-independent role of adiponectin? J Endocrinol Invest. 2013; 36:1–6.
Prasad K, Havilah P. Vinodh P. A study of vitamin D and metabolic syndrome in urban population. Int J Biol Med Res.2012; 3(2):1731- 1734.
García-Hermoso A, Ceballos-Ceballos RJM, Poblete-Aro CE, Hackney AC, Mota J, Ramírez-Vélez R, 2016. Exercise, adipokines and pediatric obesity: a meta analysis of randomized controlled trials. Inter J Obesity;
:475.
Stewart R, Sabbah W, Tsakos G, D'Aiuto F, Watt RG. Oral health and cognitive function in the Third National Health and Nutrition Examination Survey (NHANES III). Psychosomatic med. 2008; 70:936-41.
Rammos G, Tseke P, Ziakka S. Vitamin D, the renin- angiotensin system, and insulin resistance. Int Urol Nephr. 2008; 40(2):419-426.
Youssef MM, El-Toukhy S, Wafay H, Salah EM, Salem SM, Megahed HS, et al, The Association of Vitamin D Status and Parathormone Level with Obesity In Egyptian School Children. Int J Acad Res.2012; 4(4):98- 107.
Mauss D, Jarczok MN, Hoffmann K, Thomas GN, Fischer JE. Association of vitamin D levels with type 2 diabetes in older working adults. Int J Med sci. 2015; 12(5):362. Doi: 10.7150/ijms.10540
Peterson CA, Tosh AK, Belenchia AM. Vitamin D insufficiency and insulin resistance in obese adolescents. Therapadv Endocrin Metab. 2014; 5(6): 166- 189. DOI: 10.1177/2042018814547205
This work is licensed under a Creative Commons Attribution 4.0 International License.